期刊文献+

外周血造血干细胞输注对异基因造血干细胞移植后复发和排异的疗效观察

在线阅读 下载PDF
导出
摘要 目的观察外周血干细胞采集物输注(DSI)对造血干细胞移植(HSCT)后复发及排异的疗效,评价其疗效和安全性。方法对3例异基因造血干细胞移植后行DSI的患者,进行回顾性研究,观察其对复发和排异的影响。结果 1例急性淋巴细胞白血病异基因移植后复发的患者行DSI后再次获得缓解,但发生严重GVHD于1年后死亡,1例重型再生障碍性贫血异基因移植后血象及STR下降的患者,DSI后血象恢复,STR升至100%供者,随访至今病情稳定,未发生GVHD,1例急性髓系白血病移植后重度GVHD但骨髓缓解的患者,DSI后GVHD明显减轻,随访至今未复发。结论 DSI对移植后复发具有较好的治疗作用,但其是否对药物治疗无效的GVHD具有治疗作用仍需进一步研究。
出处 《中国医药指南》 2018年第19期136-137,共2页 Guide of China Medicine
  • 相关文献

参考文献6

二级参考文献55

  • 1刘代红,黄晓军,陈欢,许兰平,刘开彦,韩伟,陆道培.异基因造血干细胞移植后供者外周血造血干细胞输注预防高危白血病复发[J].中华血液学杂志,2006,27(1):6-9. 被引量:21
  • 2Porter DL,Collins RH,Hardy C,et al.Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions.Blood,2000,95:1214-1221.
  • 3Nicholas BH,Mhairi C,Karen S,et al.Complete molecular responses are achieved after reduced intensity stem cell transplantation and donor lymphocyte infusion in chronic myeloid leukemia.Blood,2008,111:5252-5255.
  • 4Komori T,Sugiyama H,Ogawa H,et al.Treatment of a patient in a relapse after bone marrow transplantation for acute lymphoblastic leukemia with the systemic administration of allogeneic lymphokineactivated killer cells and recombinant interleukin-2.Eur J Haematol,1989,43:184-185.
  • 5Slavin S,Naparstek E,Nagler A,et al.Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.Exp Hematol,1995,23:1553-1556.
  • 6Kolb HJ,Schattenberg A,Goldman JM,et al.Graft-versus-leukemia effects of donor lymphocyte transfusions in marrow grafted working party chronic leukemia.Blood,1995,86:2041-2043.
  • 7van Rhee F,Savage D,Blackwell J,et al.Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant:equal efficacy of lymphocyte from sibling and matched unrelated donors.Bone Marrow Transplant,1998,21:1055-1061.
  • 8Ji SQ,Chen HR,Yun HM,et al.Anti-CD25 monoclonal antibody for prevention of GVHD after haploidentical bone marrow transplatation for hematological malignancies.Bone Marrow Transplant,2005,36:349-354.
  • 9Aversa F,Terenzi A,Tabilio A,et al.Full haplotype-mismatched hematopoietic stem-cell transplantation:a phase Ⅱ study in patients with acute leukemia at high risk of relapse.J Clin Oncol,2005,23:3447-3454.
  • 10Schleuning M. Adoptive allogeneic immunotherapy-history and future perspectives. Transfusion Sci, 2000, 3: 133-150.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部